Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Knowing when to choose cash back over points on credit cards can save you money. Learn the scenarios that favor cash back!
27,373 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Peloton posted a GAAP profit in its latest quarter and raised full-year guidance, sparking an 11% premarket jump as i...
As AI accelerates, the Microsoft-OpenAI relationship faces shifts. This piece explains why microsoft distancing itsel...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
IBM recently released a preliminary quarter that underscored a broader pattern: AI budgets are shifting. This article...
Three fast-growing tech names are drawing July attention, each amid clear AI-driven catalysts and strong quarterly ga...
Imagine a Corcept director with 1.5 million shares weathering a 50% stock crash and a strong rebound. This article br...
Earnings season often brings volatility, but a post-earnings sell-off could incredible offer a rare entry point for p...
When geopolitics roils markets, the duration of the shock matters most. This week, investors should focus on how long...
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
A surge in Planet Labs shares has traders buzzing. This guide explains the drivers behind the move, the risks involve...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...